Business Description
Synlogic Inc
NAICS : 325412
SIC : 2834
ISIN : US87166L1008
Description
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.34 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 1.1 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -34.6 | |||||
| Beneish M-Score | 2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 31.5 | |||||
| 3-Year EBITDA Growth Rate | 28.9 | |||||
| 3-Year EPS without NRI Growth Rate | 30.5 | |||||
| 3-Year FCF Growth Rate | 21.9 | |||||
| 3-Year Book Growth Rate | -53.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 71.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 126.74 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.13 | |||||
| 9-Day RSI | 49.86 | |||||
| 14-Day RSI | 48.79 | |||||
| 6-1 Month Momentum % | -11.25 | |||||
| 12-1 Month Momentum % | -27.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.71 | |||||
| Quick Ratio | 2.71 | |||||
| Cash Ratio | 2.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -53.4 | |||||
| Shareholder Yield % | -98.98 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -901.15 | |||||
| Net Margin % | -1591.75 | |||||
| FCF Margin % | -1320.13 | |||||
| ROE % | -172.03 | |||||
| ROA % | -100.35 | |||||
| ROIC % | -135.89 | |||||
| ROC (Joel Greenblatt) % | -234.5 | |||||
| ROCE % | -132.75 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.64 | |||||
| PB Ratio | 1.26 | |||||
| Price-to-Tangible-Book | 1.26 | |||||
| EV-to-EBIT | 0.07 | |||||
| EV-to-EBITDA | 0.07 | |||||
| EV-to-Revenue | -1.09 | |||||
| EV-to-Forward-Revenue | 1.1 | |||||
| EV-to-FCF | 0.08 | |||||
| Price-to-Net-Current-Asset-Value | 1.26 | |||||
| Price-to-Net-Cash | 1.41 | |||||
| Earnings Yield (Greenblatt) % | 1428.57 | |||||
| FCF Yield % | -222.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SYBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synlogic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.777 | ||
| EPS (TTM) ($) | -4.032 | ||
| Beta | 0.65 | ||
| Volatility % | 84.86 | ||
| 14-Day RSI | 48.79 | ||
| 14-Day ATR ($) | 0.07162 | ||
| 20-Day SMA ($) | 1.414825 | ||
| 12-1 Month Momentum % | -27.92 | ||
| 52-Week Range ($) | 1.22 - 5.1181 | ||
| Shares Outstanding (Mil) | 11.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synlogic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synlogic Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Synlogic Inc Frequently Asked Questions
What is Synlogic Inc(SYBX)'s stock price today?
The current price of SYBX is $1.41. The 52 week high of SYBX is $5.12 and 52 week low is $1.22.
When is next earnings date of Synlogic Inc(SYBX)?
The next earnings date of Synlogic Inc(SYBX) is 2025-03-19 Est..
Does Synlogic Inc(SYBX) pay dividends? If so, how much?
Synlogic Inc(SYBX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers